Hostname: page-component-669899f699-cf6xr Total loading time: 0 Render date: 2025-04-27T06:15:54.218Z Has data issue: false hasContentIssue false
  • English
  • Français

Primary care triaging of head and neck cancer referrals using the head and neck cancer risk calculator version 2: impact on a tertiary head and neck service

Published online by Cambridge University Press:  23 August 2022

L Li Open the ORCID record for L Li [Opens in a new window] ,
T Tikka ,
C Morton ,
C Chan ,
L Hayois ,
M Henderson ,
C Hastie ,
L Lee ,
L Porteus  and
I Nixon
L Li*
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh, UK Department of Otorhinolaryngology – Head and Neck Surgery, NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, UK
T Tikka
Affiliation:
Department of Otorhinolaryngology – Head and Neck Surgery, NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, UK
C Morton
Affiliation:
General Practitioner Referral Advisor Team, NHS Lothian, Edinburgh, UK
C Chan
Affiliation:
University of Edinburgh Medical School, University of Edinburgh, UK
L Hayois
Affiliation:
University of Edinburgh Medical School, University of Edinburgh, UK
M Henderson
Affiliation:
University of Edinburgh Medical School, University of Edinburgh, UK
C Hastie
Affiliation:
University of Edinburgh Medical School, University of Edinburgh, UK
L Lee
Affiliation:
University of Edinburgh Medical School, University of Edinburgh, UK
L Porteus
Affiliation:
Cancer and Palliative Care, NHS Lothian, Edinburgh, Scotland, UK
I Nixon
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh, UK
*
Author for correspondence: Dr L Li, Department of Otorhinolaryngology – Head and Neck Surgery, NHS Lothian, Lauriston Building, 41 Lauriston Place, Edinburgh, EH3 9HB, UK E-mail: lucyli@doctors.org.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

This study aimed to investigate the use of the head and neck cancer risk calculator version 2 in a primary care setting and to evaluate the impact of the risk calculator on the number of referrals stratified by urgency and cancer yield.

Method

Referrals between April 2019 and August 2019, April 2020 and July 2020 (pre-risk calculator) and August 2020 and July 2021 (post-risk calculator) were analysed. Referral urgency, head and neck cancer risk calculator version 2 score, cancer diagnosis, cancer type and further investigations were recorded.

Results

The 2023 patient encounters were analysed; there were 1110 (55 per cent) referrals before head and neck cancer risk calculator version 2 use and 913 (45 per cent) after head and neck cancer risk calculator version 2 use. A higher proportion of older (p < 0.001) and male (p < 0.013) patients were seen post-head and neck cancer risk calculator version 2 use. All cancer cases were seen on the urgent suspicion of cancer pathway post-head and neck cancer risk calculator version 2 use; however, a higher proportion of patients were seen as urgent suspicion of cancer (51.1 vs 83.5 per cent; p < 0.001). Overall, the cancer diagnosis rate increased from 2.7 to 4.1 per cent.

Conclusion

The head and neck cancer risk calculator version 2 had high sensitivity in cancer diagnosis. More studies are required to optimise the predicted versus actual cancer probability gap.

Keywords

Head And Neck NeoplasmCovid-19TriagePrimary CareReferral And Consultation
Type
Main Article
Information
The Journal of Laryngology & Otology , Volume 137 , Issue 7 , July 2023 , pp. 763 - 768
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Dr L Li takes responsibility for the integrity of the content of the paper

References

Public Health Scotland. Cancer statistics: head and neck cancer. In: https://www.isdscotland.org/health-topics/cancer/cancer-statistics/head-and-neck/ [12 March 2022]Google Scholar
NICE. Suspected cancer: recognition and referral. NICE guideline (NG12). In: www.nice.org.uk/guidance/ng12 [12 March 2022]Google Scholar
Scottish Government. Scottish referral guidelines for suspected cancer: quick reference guide. In: www.scotland.gov.uk/quickreferenceguide/suspectedcancer [12 March 2022]Google Scholar
Lyons, M, Philpott, J, Hore, I, Watters, G. Audit of referrals for head and neck cancer - the effect of the 2-week, fast track referral system. Clin Otolaryngol Allied Sci 2004;29:143–510.1111/j.0307-7772.2004.00744.xCrossRefGoogle ScholarPubMed
Hobson, JC, Malla, JV, Sinha, J, Kay, NJ, Ramamurthy, L. Outcomes for patients referred urgently with suspected head and neck cancer. J Laryngol Otol 2008;122:1241–410.1017/S0022215108002004CrossRefGoogle ScholarPubMed
McKie, C, Ahmad, UA, Fellows, S, Meikle, D, Stafford, FW, Thomson, PJ et al. The 2-week rule for suspected head and neck cancer in the United Kingdom: referral patterns, diagnostic efficacy of the guidelines and compliance. Oral Oncol 2008;44:851–610.1016/j.oraloncology.2007.10.010CrossRefGoogle ScholarPubMed
Tikka, T, Pracy, P, Paleri, V. Refining the head and neck cancer referral guidelines: a two-centre analysis of 4715 referrals. Clin Otolaryngol 2016;41:66–7510.1111/coa.12597CrossRefGoogle ScholarPubMed
Tikka, T, Paleri, V, MacKenzie, K. External validation of a cancer risk prediction model for suspected head and neck cancer referrals. Clin Otolaryngol 2018;43:714–710.1111/coa.13019CrossRefGoogle ScholarPubMed
Lau, K, Wilkinson, J, Moorthy, R. A web-based prediction score for head and neck cancer referrals. Clin Otolaryngol 2018;43:1043–910.1111/coa.13098CrossRefGoogle ScholarPubMed
Tikka, T, Kavanagh, K, Lowit, A, Jiafeng, P, Burns, H, Nixon, IJ et al. Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors. Clin Otolaryngol 2020;45:380–810.1111/coa.13511CrossRefGoogle ScholarPubMed
Round, T, Ashworth, M, L'Esperance, V, Moller, H. Cancer detection via primary care urgent referral and association with practice characteristics: a retrospective cross-sectional study in England from 2009/2010 to 2018/2019. Br J Gen Pract 2021;71:e826–3510.3399/BJGP.2020.1030CrossRefGoogle ScholarPubMed
Montgomery, J, Douglas, CM, Begbie, F, Hitchings, A, MacKenzie, K. 'Urgent suspicion of cancer' referrals to a head and neck clinic - what do patients expect? J Laryngol Otol 2019;133:782–710.1017/S0022215119001543CrossRefGoogle ScholarPubMed
Banerjee, S, Voliotidis, D, Parvin, L, Rama, SPK. Telephone triage of suspected head and neck cancer patients during the coronavirus disease 2019 pandemic using the Head and Neck Cancer Risk Calculator version 2. J Laryngol Otol 2021;135:241–510.1017/S0022215121000657CrossRefGoogle ScholarPubMed
Hardman, JC, Tikka, T, Paleri, V, Ent, Uk B, Integrate. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study. Cancer 2021;127:4177–8910.1002/cncr.33800CrossRefGoogle ScholarPubMed
Kaddour, H, Jama, GM, Stagnell, S, Kaddour, S, Guner, K, Kumar, G. Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic. Eur Arch Otorhinolaryngol 2022;279:1111–510.1007/s00405-021-07135-3CrossRefGoogle ScholarPubMed
Warner, E, Scholfield, DW, Adams, A, Richards, P, Ali, S, Ahmed, J et al. North East London coronavirus disease 2019 protocol for diagnostics in two-week wait head and neck cancer patients. J Laryngol Otol 2020;134:680–310.1017/S0022215120001267CrossRefGoogle ScholarPubMed
Metcalfe, C, Dogan, M, Glazzard, N, Ross, E, George, A. Introduction of a novel telescopic pathway to streamline 2-week-wait suspected head and neck cancer referrals and improve efficiency: A prospective service evaluation. Laryngoscope Investig Otolaryngol 2022;7:117–2410.1002/lio2.721CrossRefGoogle ScholarPubMed